Human IGG B12 anti- primary HIV-1 isolates (PDB: 1HZH)
Welcome To The Antibody Society Webpage
The Antibody Society was formed in 2007 to further the broad interests of antibody engineering and antibody therapeutics, as well as to safeguard the public interest by increasing discussion and activities to create the safe, thorough testing of antibody therapeutics. The Society encompasses this increasingly diverse field, by supporting the superstructure for the engineering of recombinant antibodies, single scaffold binders, etc. through basic and applied research by those in academics and the private sector. The Society also seeks to provide a forum and voice for the thousands of people now working on all facets of this global field. Read our Mission Statement.
The Antibody Society membership.The Antibody Society website is the vehicle for registration of new members, which is now possible via a secure online server,register here !
News and views
IBC's – Antibody Engineering & Therapeutics – Now in its 24th year, Antibody Engineering & Therapeutics has earned its reputation by consistently offering the most current academic research findings and most recent industry updates. Our attendees ...
Find out more !
Antibody Society members save 25% on registration for the Antibody Engineering Therapeutics meeting!
Contact Dr Berend Tolner (b.tolner@ucl.ac.uk) from The Antibody Society now for the discount code.
Meeting Report 2012 San Diego, now available – A Meeting Report of the 2012 meeting in San Diego has been published in MABS and can be found
here !
Most influential people of the global antibody industry – Who are the top 50 most influential people of the global antibody industry today? Many of The Antibody Society's members, according to a survey by Terrapinn available
here!
Listing of approved monoclonal antibodies ! A list has been composed of all therapeutic monoclonal antibodies approved or in review in the European Union or United States.Find the table here !
GIATE: new developments !
GIATE: Guidelines for Information About Therapy Research Experiments.
Fulfilling a need in data management:
•Use to organise your data and track workflow
•Share data within your group and with collaborators
•Enjoy improved ability to plan, retrieve, analyse and report research
Submissions are due as soon as possible, but no later than the end of JUNE. Please identify these submissions to PEDS as being for the Antibody Special Issue (PEDS-ASI) and they will receive an expedited review.
Use your personal or institutional subscriptions for access to PEDS. After one
year all papers published in PEDS are Open Access.
Broad coverage of all topics relevant
to antibody research and development
mAbs is the therapeutics journal of The Antibody Society !
